Axinn Promotes Craig Minerva to Partner, Rebecca Clegg and Kail Jethmalani to Counsel

Axinn is pleased to announce that Craig Minerva, a member of the firm’s Antitrust practice group, has been promoted to partner. Additionally, Rebecca Clegg of the firm’s Intellectual Property practice group and Kail Jethmalani of the firm’s Antitrust practice group have both been promoted to Counsel. The promotions are effective as of January 1, 2023.

“We are delighted to share the well-deserved promotions of Craig, Rebecca, and Kail,” says Axinn Managing Partner Matthew Becker. “Their contributions to our core practice areas and clients over the last several years are impressive, and these elevations reflect our confidence in their continued success at Axinn.”

Craig Minerva, based in Axinn’s Washington, D.C. office, is a former lead attorney with the Antitrust Division of the U.S. Department of Justice, where he led a number of high-profile matters, including the merger investigations of Disney/Fox, Visa/Plaid, Quad Graphics/LSC Communications, and Chicago Tribune/Chicago Sun-Times. Craig’s notable client representations include VMware on its proposed $69 billion acquisition by Broadcom, Thermo Fisher Scientific in its $12.5 billion tender offer for Qiagen, D.G. Yuengling & Son in its joint venture with Molson Coors Beverage Company to expand geographically, and Sagard Holdings, Fairfax Financial Holdings, and Peak Achievement Athletics in the acquisition of Easton Diamond Sports by Rawlings Sporting Goods. He also has counseled a number of technology and pharmaceutical companies on a variety of non-public matters including government conduct investigations, potential transactions, and proposed business conduct. Having previously worked in London on a detail assignment, Craig also has advised clients on European and UK competition law issues and has significant international experience.

Rebecca Clegg is based in the firm’s Hartford office and her practice focuses on complex intellectual property litigation and counseling, particularly in the fields of medical devices, pharmaceuticals, biotechnology, and semiconductors. Rebecca regularly litigates Hatch-Waxman Paragraph IV patent infringement suits, and has represented several generic pharmaceutical companies in these litigations. She also has experience representing clients in commercial litigation cases, including defending a financial industry service provider from multiple indemnification claims brought by a bank.

Kail Jethmalani, based in Axinn’s New York office, has experience with both domestic and cross-border M&A transactions, representing clients before the U.S. Department of Justice, Federal Trade Commission, and competition regulators in Europe, China, Korea, Japan, India, and other jurisdictions. He also counsels clients on antitrust issues relating to their core business practices, and represents clients in multi-district litigations around the country, as well as in sensitive government and internal investigations. Additionally, Kail maintains an active pro bono practice and has been recognized by The New York State Bar Association for his pro bono contributions through the Empire State Counsel program.